Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-25 @ 11:17 PM
Study NCT ID:
NCT04290793
Status:
UNKNOWN
Last Update Posted:
2020-03-02
First Post:
2020-02-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-02-27
First Submit QC Date:
None
Study First Post Date:
2020-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-27
Last Update Post Date:
2020-03-02
Last Update Post Date Type:
ACTUAL